Blogs
From Aiosyn blog: Diana Rosentul, a Regulatory Affairs Specialist at Aiosyn, intricately manages the regulatory landscape associated with the integration of AI-based solutions within clinical and research institutions. Drawing upon her...
From HIT Consultant regarding PathAI: What You Should Know: PathAI, a pioneer in AI-powered pathology, announced a significant expansion of its PathExplore platform, adding six new oncology indications to its arsenal. The expansion...
From the Proscia blog: The United Kingdom (UK) National Screening Committee recently released a recommendation on the critical role of digital pathology, and, in response, the government has agreed to its broader implementation. This comes...
The shift towards digital pathology has marked a significant advancement in breast cancer diagnosis. High-resolution digital imaging of slides provides pathologists with an unprecedentedly clear and expansive view of tissue samples for their...
From the Lumea Podcast - Ask A Pathologist: In our fifth Ask a Pathologist Podcast episode we had the privilege to interview Dr. Hillel Kahane about his favorite game-changing tools for pathologists. From pre-analytical tools to digital...
Cancer mortality in the U.S. has fallen over the past three decades, but increases in common forms of the disease pose a threat to that progress. The number of new cancer cases in the U.S. is expected to top 2 million for the first time in...
